Speaker Abstracts
All abstracts are in PDF format.
Hilary Calvert (University College London)
Clinical Development of Carboplatin: Succeeding Slowly is Better than Failing Fast
Michael Cleare (Skysong Innovations)
Serendipity, Persistence and Innovative Clinicians: Comments on the Research, Development and Approval of Carboplatin
The Pre-History and Future of Platinum Anticancer Drugs
James Hoeschele (Eastern Michigan University)
Discovery of the Antitumor Activity of Cisplatin: Participants, Events and Impact
Understanding and Improving Cisplatin
Bernhard Lippert (Technische Universität Dortmund)
Working with Barnett Rosenberg: A Personal Appreciation of my Postdoctoral Time at MSU and on an Exciting Project, the Platinum Pyrimidine Blue
Deciphering Metabolic Rewiring in Cancer
Precision Nanomedicine in Cancer Therapy
Platinums, BRCA Mutations, Impaired DNA Repair: Factors in the Cure of Women’s Cancer
Therapeutic Applications of Small Molecule Proteasome Activation